XML 73 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
PARENT COMPANY CONDENSED FINANCIAL INFORMATION (Tables)
12 Months Ended
Dec. 31, 2023
PARENT COMPANY CONDENSED FINANCIAL INFORMATION  
Schedule of balance sheets

December 31, (in thousands)

    

2023

    

2022

Assets:

Cash and cash equivalents

$

37,778

$

36,436

Securities available for sale

5,872

3,855

Investment in bank subsidiary

 

875,503

 

819,144

Investment in non-bank subsidiaries

 

 

2,773

Other assets

 

2,598

 

2,465

Total assets

$

921,751

$

864,673

Liabilities and Stockholders’ Equity:

Other liabilities

 

8,995

 

8,060

Stockholders’ equity

 

912,756

 

856,613

Total liabilities and stockholders’ equity

$

921,751

$

864,673

Schedule of statements of income

Years Ended December 31, (in thousands)

    

2023

    

2022

    

2021

Income and expenses:

Dividends from subsidiary

$

48,000

$

59,460

$

28,300

Interest income

 

429

 

229

 

143

Other income

 

(37)

 

54

 

53

Less: Interest expense

 

 

 

507

Less: Other expenses

 

1,097

 

819

 

760

Income before income tax benefit

 

47,295

 

58,924

 

27,229

Income tax benefit

 

166

 

124

 

245

Income before equity in undistributed net income of subsidiaries

 

47,461

 

59,048

 

27,474

Equity in undistributed net income of subsidiaries

 

42,913

 

32,058

 

60,137

Net income

$

90,374

$

91,106

$

87,611

Comprehensive income

$

101,945

$

57,253

$

80,976

Schedule of statements of cash flows

Years Ended December 31, (in thousands)

    

2023

    

2022

    

2021

Operating activities:

Net income

$

90,374

$

91,106

$

87,611

Adjustments to reconcile net income to net cash provided by operating activities:

Accretion of investment securities

(59)

(56)

(53)

Equity in undistributed net income of subsidiaries

 

(42,913)

 

(32,058)

 

(60,137)

Director deferred compensation

 

769

 

427

 

347

Change in other assets

 

(1,639)

 

4,571

 

(736)

Change in other liabilities

 

3,973

 

(5,428)

 

1,694

Net cash provided by operating activities

 

50,505

 

58,562

 

28,726

Investing activities:

Investment in venture capital fund

 

(532)

 

(337)

 

Investment in subsidiary bank

(627)

(590)

(591)

Net cash used in investing activities

 

(1,159)

 

(927)

 

(591)

Financing activities:

Common Stock repurchases

 

(20,279)

(12,577)

 

(47,528)

Net proceeds from Class A Common Stock purchased through employee stock purchase plan

627

590

591

Net proceeds from Common Stock options exercised and equity awards

 

(2)

 

52

 

(142)

Payoff of subordinated note, net of common security interest

(40,000)

Cash dividends paid

 

(28,350)

 

(26,145)

 

(24,699)

Net cash used in financing activities

 

(48,004)

 

(38,080)

 

(111,778)

Net change in cash and cash equivalents

 

1,342

 

19,555

 

(83,643)

Cash and cash equivalents at beginning of period

 

36,436

 

16,881

 

100,524

Cash and cash equivalents at end of period

$

37,778

$

36,436

$

16,881